MONEY

Capricor Therapeutics shares rise as FDA decision nears

ByFinance Desk

Nov 11, 2026 , , , , , , , ,

Capricor Therapeutics shares rise as FDA decision nears

Source link

By Finance Desk

Related Post

MONEY

StubHub raises 2026 GMS outlook to 11%-13% growth while reiterating $400M-$420M adjusted EBITDA (NYSE:STUB)

Nov 11, 2026 Finance Desk
MONEY

Satellogic outlines mid-2027 transfers for $37M sovereign deal while booking launch slots through H1 2029 (NASDAQ:SATL)

Nov 11, 2026 Finance Desk
MONEY

Gen Restaurant Group targets $40M CPG revenue run rate by end of 2027 while planning ~75% overhead cut (NASDAQ:GENK)

Nov 11, 2026 Finance Desk

Leave a Reply

You missed

SHOW BIZ

Stacy Keach, actor known for playing detective Mike Hammer, dies at 85

Nov 11, 2026 News Desk
MONEY

StubHub raises 2026 GMS outlook to 11%-13% growth while reiterating $400M-$420M adjusted EBITDA (NYSE:STUB)

Nov 11, 2026 Finance Desk
POLITICS

Newsom heads to Turkey for climate conference, blasts ‘no-show’ Trump

Nov 11, 2026 Politics Desk
SPORT

MLB GM Meetings: Takeaways from Dodgers’ Brandon Gomes

Nov 11, 2026 Sports Desk

Discover more from Occasional Digest

Subscribe now to keep reading and get access to the full archive.

Continue reading